Dickson et al. showed that a single dose of the anti-VEGF antibody BVZ caused an overall decrease in tumor microvascular density by destroying the immature vessels and improving tumor perfusion and responsiveness to chemotherapy in neuroblastoma xenografts [32]. The gene discussed is VEGFA; the disease is neoplasm.